William P Forbes Insider Trading $SLXP SALIX PHARMACEUTICALS LTD

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for William P Forbes.

  • Your email is safe with us.
  • The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of William P Forbes. William P Forbes is EVP Research&Devel & CDO in SALIX PHARMACEUTICALS LTD ($SLXP).

William P Forbes in SALIX PHARMACEUTICALS LTD

Trading Symbol: SLXP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of William P Forbes: EVP Research&Devel & CDO
Holdings: 114,594 shares
Latest Transaction: Jan 08 2015

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of William P Forbes in SALIX PHARMACEUTICALS LTD

1 Week2 Weeks1 Month3 Months6 Months1 Year2 Years
No. of Purchases0000000
Value of Purchases ($)0000000
No. of Sales0000000
Value of Sales ($)0000000

Page:   1

DateTickerCompanyOwnerRelationship Transaction Code Cost ($) Shares Transaction Value ($) Total Shares % Holdings
Jan 08 2015SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...Payment of ExerciseF114.9410,9971,263,995114,594125.6 K to 114.6 K (-8.76 %)
Nov 14 2014SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...Option ExerciseM17.636,250110,1880
Nov 14 2014SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...Option ExerciseM17.5311,200196,3360
Nov 14 2014SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...SellS95.0511,0791,053,059125,591136.7 K to 125.6 K (-8.11 %)
Nov 14 2014SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...BuyM17.636,250110,188136,670130.4 K to 136.7 K (+4.79 %)
Nov 14 2014SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...BuyM17.5311,200196,336130,420119.2 K to 130.4 K (+9.39 %)
Aug 26 2014SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...GrantA158.3019,8093,135,765119,22099.4 K to 119.2 K (+19.93 %)
Jul 03 2014SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...Payment of ExerciseF123.351,971243,12399,411101.4 K to 99.4 K (-1.94 %)
Apr 21 2014SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...GrantA100.6619,8091,993,974101,38281.6 K to 101.4 K (+24.28 %)
Jan 10 2014SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...Option ExerciseM17.538,000140,24011,200
Jan 10 2014SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...SellS90.068,000720,48081,57389.6 K to 81.6 K (-8.93 %)
Jan 10 2014SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...BuyM17.538,000140,24089,57381.6 K to 89.6 K (+9.81 %)
Jan 06 2014SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...Payment of ExerciseF89.948,851796,05981,57390.4 K to 81.6 K (-9.79 %)
Jul 26 2013SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...Option ExerciseM17.5312,000210,36019,200
Jul 26 2013SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...SellS71.883,000215,64090,42493.4 K to 90.4 K (-3.21 %)
Jul 26 2013SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...SellS70.966,000425,76093,42499.4 K to 93.4 K (-6.03 %)
Jul 26 2013SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...SellS69.913,000209,73099,424102.4 K to 99.4 K (-2.93 %)
Jul 26 2013SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...BuyM17.5312,000210,360102,42490.4 K to 102.4 K (+13.27 %)
Jul 03 2013SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...Payment of ExerciseF66.154,835319,83590,42495.3 K to 90.4 K (-5.08 %)
Apr 22 2013SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...GrantA48.7023,7411,156,18795,25971.5 K to 95.3 K (+33.20 %)
Apr 12 2013SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...Option ExerciseM17.5313,000227,89031,200
Apr 12 2013SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...SellS49.378,673428,18671,51880.2 K to 71.5 K (-10.82 %)
Apr 12 2013SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...BuyM17.5313,000227,89080,19167.2 K to 80.2 K (+19.35 %)
Jan 04 2013SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...Payment of ExerciseF40.475,052204,45467,19172.2 K to 67.2 K (-6.99 %)
Jul 05 2012SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...Payment of ExerciseF54.444,107223,58572,24376.4 K to 72.2 K (-5.38 %)
May 21 2012SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...Option ExerciseM17.5310,000175,30044,200
May 21 2012SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...SellS52.262,900151,55476,35079.3 K to 76.4 K (-3.66 %)
May 21 2012SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...SellS51.357,100364,58579,25086.4 K to 79.3 K (-8.22 %)
May 21 2012SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...BuyM17.5310,000175,30086,35076.4 K to 86.4 K (+13.10 %)
Apr 27 2012SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...GrantA0.0020,713076,35055.6 K to 76.4 K (+37.23 %)
Feb 15 2012SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...Option ExerciseM17.534,29775,32654,200
Feb 15 2012SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...SellS50.004,297214,85055,63759.9 K to 55.6 K (-7.17 %)
Feb 15 2012SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...BuyM17.534,29775,32659,93455.6 K to 59.9 K (+7.72 %)
Feb 07 2012SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...Option ExerciseM17.532594,54058,497
Feb 07 2012SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...SellS50.0025912,95055,63755.9 K to 55.6 K (-0.46 %)
Feb 07 2012SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...BuyM17.532594,54055,89655.6 K to 55.9 K (+0.47 %)
Jan 19 2012SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...Option ExerciseM17.531252,19158,756
Jan 19 2012SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...Option ExerciseM17.531,11919,61658,881
Jan 19 2012SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...SellS50.001256,25055,63755.8 K to 55.6 K (-0.22 %)
Jan 19 2012SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...BuyM17.531252,19155,76255.6 K to 55.8 K (+0.22 %)
Jan 19 2012SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...SellS50.061,11956,01655,63756.8 K to 55.6 K (-1.97 %)
Jan 19 2012SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...BuyM17.531,11919,61656,75655.6 K to 56.8 K (+2.01 %)
Jan 05 2012SLXPSALIX PHARMACEUTIC ...Forbes William PEVP Research&Devel ...Payment of ExerciseF47.852,506119,91255,63758.1 K to 55.6 K (-4.31 %)

Page:   1

Contact us | Follow us on Twitter